Long-Term NSAID Use May Lower Cutaneous Melanoma Risk.
MedWire (7/8, Albert) reported, "Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) appears to reduce the risk for cutaneous melanoma," according to a study published in the Journal of Investigative Dermatology. In a study involving "400 cutaneous-melanoma patients, aged 60 years on average, and 600 age- and gender-matched controls," researchers discovered that people "who regularly used NSAIDs for over five years had a significant 43% decreased risk for developing cutaneous [melanoma], compared with those who used NSAIDs for less than two years or not at all." Those who used aspirin for more than five years had a 49% decreased risk for melanoma.
